From Bench to Market: A Biotech Valuation and Forecasting Playbook - Paperback

by Tristan A. Yeung (Author), Jean C. Cruz (Author), Jess Lomas (Editor)

Whether you're a founder navigating your next capital raise, an investor sizing up a new therapy, or a physician-scientist eager to see your discovery reach patients, this practical and hands-on playbook will become your indispensable companion for biotech valuation and forecasting.

"A must-read if you are serious about starting, growing, or exiting a biotech startup. Founders and biotech executives would be remiss if this book were not on their bookshelves." - Joseph C. Wu, MD, PhD, Director, Stanford Cardiovascular Institute

"The essential guide I wish existed when I began my own journey at the intersection of science, medicine, and business. A rare blend of clarity, practicality, and inspiration." - Jorge Cortell, Senior Advisor, Healthcare and Life Sciences, Harvard Innovation Labs

"What sets this book apart is its clarity of purpose: to equip biotech entrepreneurs with the tools to navigate the complex journey from idea to impact." - Ko-Chung Lin, PhD, Founder and CEO, PharmaEssentia

"Truly an important read for all stages of biotech growth, providing extremely helpful scenarios from innovation to integration." - Peter J. Fitzgerald, MD, PhD, Co-founder and Managing Partner, Triventures

Master biotech valuation and forecasting to gain negotiating power and speak the universal language of investment. Learn the essential toolkit for quantifying product value through these key disciplines:

• Market Assessment - Convert epidemiological data into addressable patient populations using market trends and competitive intelligence.
• Product Dynamics - Forecast launch curves, peak penetration scenarios, and loss-of-exclusivity revenue decline.
• R&D Risk Analysis - Quantify development uncertainty using therapeutic-specific success probabilities, clinical trial costs, and completion timelines.
• Commercial Infrastructure - Model sales force requirements, marketing investments, and operational expenses from pre-launch through maturity.
• Financial Modeling - Build complete risk-adjusted NPV models using hands-on case studies and downloadable Excel templates.

Featuring up-to-date industry benchmarks, step-by-step methodologies, and proven frameworks, you will confidently evaluate biotech investments, build compelling investment cases, and navigate the unique risks and opportunities across therapeutic areas. Develop business fluency in biotech valuation to unlock your investment and negotiating potential!